Skip to main content
. 2009 Sep 15;101(8):1274–1281. doi: 10.1038/sj.bjc.6605326

Table 2. Characteristics of lesions found at colonoscopy and iFOBT result (ng ml−1).

        Range
Percentile
iFOBT positives (⩾50 ng ml−1) N (%) Mean (95% CI) Min Max 25th Median 75th
Without colonoscopy 98 (19) 455 (326–583) 52 2916 76 144 497
With colonoscopy 428 (81) 434 (377–492) 50 4168 80 175 482
Neither cancer nor adenomasa 134 (31) 314 (239–388) 50 2818 76 125 347
Non-advanced Adenomasb 105 (25) 356 (232–481) 50 4168 69 109 326
Advanced Adenomasc 161 (38) 523 (420–627) 52 3322 100 251 582
Cancerd 28 (7) 785 (563–1008) 59 1871 283 662 1226
 Stage I or II cancer 19 (68) 652 (400–904) 59 1871 280 384 1099
 Stage III or IV cancer 9 (32) 1066 (662–1470) 202 1845 622 1182 1635

Abbreviation: iFOBT, immunochemical faecal occult blood test.

a

Neither cancer nor adenomas: colonoscopies without any lesions or only hyperplastic polyps, serrated adenomas or unclassified polyps.

b

Non advanced adenomas: colonoscopy with adenomas but without advanced adenomas and cancer.

c

Advanced adenomas: colonoscopies without cancer but with adenomas ⩾10 mm in size, high grade dysplasia or a villous component ⩾20%.

d

Staging according to TNM classification: there were only 4 stage II (all stage IIa, none stage IIb) and no stage IV patients. Therefore, stages I and II, and III and IV were combined.